Cargando…

Zinc Supplementation Enhances the Pro-Death Function of UPR in Lymphoma Cells Exposed to Radiation

SIMPLE SUMMARY: It is of fundamental importance to find strategies able to reduce the minimum doses of anticancer treatments, such as radiations, and concomitantly maintain efficient killing of cancer cells. The interconnection between ER stress and DNA repair may represent a promising approach to o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonnella, Roberta, Guttieri, Luisa, Gilardini Montani, Maria Saveria, Santarelli, Roberta, Bassetti, Erica, D’Orazi, Gabriella, Cirone, Mara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773084/ https://www.ncbi.nlm.nih.gov/pubmed/35053130 http://dx.doi.org/10.3390/biology11010132

Ejemplares similares

Role of UPR Sensor Activation in Cell Death–Survival Decision of Colon Cancer Cells Stressed by DPE Treatment
por: Benedetti, Rossella, et al.
Publicado: (2021)

Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death
por: Granato, Marisa, et al.
Publicado: (2017)

IRE1 Alpha/XBP1 Axis Sustains Primary Effusion Lymphoma Cell Survival by Promoting Cytokine Release and STAT3 Activation
por: Gonnella, Roberta, et al.
Publicado: (2021)

Lovastatin reduces PEL cell survival by phosphorylating ERK1/2 that blocks the autophagic flux and engages a cross‐talk with p53 to activate p21
por: Santarelli, Roberta, et al.
Publicado: (2021)

Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP: A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell Lymphomas
por: Benedetti, Rossella, et al.
Publicado: (2022)

NRF2 and STAT3: friends or foes in carcinogenesis?
por: Arena, Andrea, et al.
Publicado: (2023)

NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma Cells
por: Arena, Andrea, et al.
Publicado: (2023)

KSHV infection skews macrophage polarisation towards M2-like/TAM and activates Ire1 α-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression
por: Gilardini Montani, Maria Saveria, et al.
Publicado: (2020)

PBA Preferentially Impairs Cell Survival of Glioblastomas Carrying mutp53 by Reducing Its Expression Level, Stabilizing wtp53, Downregulating the Mevalonate Kinase and Dysregulating UPR
por: Romeo, Maria Anele, et al.
Publicado: (2020)

STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway
por: Romeo, Maria Anele, et al.
Publicado: (2020)

Quercetin Interrupts the Positive Feedback Loop Between STAT3 and IL-6, Promotes Autophagy, and Reduces ROS, Preventing EBV-Driven B Cell Immortalization
por: Granato, Marisa, et al.
Publicado: (2019)

HSPs/STAT3 Interplay Sustains DDR and Promotes Cytokine Release by Primary Effusion Lymphoma Cells
por: Gonnella, Roberta, et al.
Publicado: (2023)

Mechanisms of Sensitivity and Resistance of Primary Effusion Lymphoma to Dimethyl Fumarate (DMF)
por: Gonnella, Roberta, et al.
Publicado: (2022)

3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells
por: Santarelli, Roberta, et al.
Publicado: (2022)

Targeting c-Myc Unbalances UPR towards Cell Death and Impairs DDR in Lymphoma and Multiple Myeloma Cells
por: Arena, Andrea, et al.
Publicado: (2022)

p53-R273H Sustains ROS, Pro-Inflammatory Cytokine Release and mTOR Activation While Reducing Autophagy, Mitophagy and UCP2 Expression, Effects Prevented by wtp53
por: Romeo, Maria Anele, et al.
Publicado: (2021)

Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response
por: Garufi, Alessia, et al.
Publicado: (2019)

Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
por: Cirone, Mara, et al.
Publicado: (2019)

Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1
por: Granato, Marisa, et al.
Publicado: (2018)

Interplay between Endoplasmic Reticulum (ER) Stress and Autophagy Induces Mutant p53H273 Degradation
por: Garufi, Alessia, et al.
Publicado: (2020)

Viral Infection and Autophagy Dysregulation: The Case of HHV-6, EBV and KSHV
por: Romeo, Maria Anele, et al.
Publicado: (2020)

VPA and TSA Interrupt the Interplay between mutp53 and HSP70, Leading to CHK1 and RAD51 Down-Regulation and Sensitizing Pancreatic Cancer Cells to AZD2461 PARP Inhibitor
por: Romeo, Maria Anele, et al.
Publicado: (2022)

c-Myc Sustains Pancreatic Cancer Cell Survival and mutp53 Stability through the Mevalonate Pathway
por: Romeo, Maria Anele, et al.
Publicado: (2022)

JNK and Macroautophagy Activation by Bortezomib Has a Pro-Survival Effect in Primary Effusion Lymphoma Cells
por: Granato, Marisa, et al.
Publicado: (2013)

p62/SQSTM1/Keap1/NRF2 Axis Reduces Cancer Cells Death-Sensitivity in Response to Zn(II)–Curcumin Complex
por: Garufi, Alessia, et al.
Publicado: (2021)

Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line
por: Gonnella, Roberta, et al.
Publicado: (2013)

Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagy
por: Granato, Marisa, et al.
Publicado: (2017)

ATF6 prevents DNA damage and cell death in colon cancer cells undergoing ER stress
por: Benedetti, Rossella, et al.
Publicado: (2022)

Acetylation increases expression, interaction with TRAPPC4 and surface localization of PD-L1
por: Romeo, Maria Anele, et al.
Publicado: (2023)

EBV infection of primary colonic epithelial cells causes inflammation, DDR and autophagy dysregulation, effects that may predispose to IBD and carcinogenesis
por: Santarelli, Roberta, et al.
Publicado: (2023)

A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status
por: Garufi, Alessia, et al.
Publicado: (2020)

Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 that Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells
por: Gilardini Montani, Maria Saveria, et al.
Publicado: (2019)

Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression
por: D’Orazi, Gabriella, et al.
Publicado: (2019)

Interconnected Adaptive Responses: A Way Out for Cancer Cells to Avoid Cellular Demise
por: D’Orazi, Gabriella, et al.
Publicado: (2022)

The Impact of COVID-19 Infection in Cancer 2020–2021
por: D’Orazi, Gabriella, et al.
Publicado: (2022)

NRF2 in Cancer: Cross-Talk with Oncogenic Pathways and Involvement in Gammaherpesvirus-Driven Carcinogenesis
por: Cirone, Mara, et al.
Publicado: (2022)

Targeting COX-2/PGE(2) Pathway in HIPK2 Knockdown Cancer Cells: Impact on Dendritic Cell Maturation
por: Garufi, Alessia, et al.
Publicado: (2012)

Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression
por: Granato, Marisa, et al.
Publicado: (2015)

Targeting of Prosurvival Pathways as Therapeutic Approaches against Primary Effusion Lymphomas: Past, Present, and Future
por: Granato, Marisa, et al.
Publicado: (2015)

The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study
por: Garufi, Alessia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f78a817cjjstdetfvhbcj2chuv